Loading...

European Regulations Will Accelerate Energy Efficient Biosolids Solutions

Published
18 Jan 25
Updated
27 Aug 25
AnalystConsensusTarget's Fair Value
NOK 24.00
24.6% undervalued intrinsic discount
27 Aug
NOK 18.10
Loading
1Y
21.1%
7D
-4.0%

Author's Valuation

NOK 24.0

24.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 5.73%

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 0.89%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget has decreased revenue growth from 19.6% to 16.6%.

Shared on12 Mar 25
Fair value Decreased 4.26%

AnalystConsensusTarget has increased revenue growth from 12.1% to 19.6%.